CE ÎNSEAMNĂ CLOTTING FACTOR ÎN ENGLEZĂ?
Coagulare
Coagularea este procesul prin care sângele se schimbă de la un lichid la un gel. Poate duce la hemostază, la întreruperea pierderii de sânge de la o navă deteriorată, urmată de reparații. Mecanismul de coagulare implică activarea, adeziunea și agregarea trombocitelor împreună cu depunerea și maturarea fibrinei. Tulburările de coagulare sunt stări de boală care pot duce la sângerare sau coagulare obstructivă. Coagularea este foarte conservată în întreaga biologie; la toate mamiferele, coagularea implică atât o componentă celulară, cât și o componentă proteică. Sistemul la om a fost cel mai cercetat și este cel mai bine înțeles. Coagularea începe aproape instantaneu după ce o leziune a vasului de sânge a afectat endoteliul care acoperă vasul. Expunerea sângelui la spațiul sub endoteliu inițiază două procese: modificări ale trombocitelor și expunerea factorului de țesut subendotalil la factorul VII de plasmă, care în cele din urmă conduce la formarea de fibrină. Trombocitele formează imediat un tampon la locul leziunii; aceasta se numește hemostază primară.
Definiția clotting factor în dicționarul Engleză
Definiția factorului de coagulare în dicționar este oricare dintr-un grup de substanțe, inclusiv factorul VIII, a cărui prezență în sânge este esențială pentru apariția coagulării sângelui. Se numește de asemenea: factor de coagulare.
CĂRȚI ÎN ENGLEZĂ ÎN LEGĂTURĂ CU «CLOTTING FACTOR»
Descoperă întrebuințarea
clotting factor în următoarea selecție bibliografică. Cărți în legătură cu
clotting factor și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Engleză.
1
Human Physiology: From Cells to Systems
However, chemical linkages rapidly form between adjacent strands to strengthen
and stabilize the clot meshwork. This cross-linkage process is catalyzed by a
clotting factor known as factor XIII (fibrin-stabilizing factor), which normally is ...
Depending on the remaining amount of coagulation factor, mild, moderate and
severe forms of hemophilia are distinguished; two-thirds of cases are severe. In
hemophilia, as a result of the clotting factor deficiency, blood does not coagulate
...
Marshall Cavendish Corporation,
2007
3
Blood: Principles and Practice of Hematology
Patient Plasma 4- aPTT aPTT Result: Correction Interpretation: Clotting Factor
Deficiency EXPLANATION EXPLANATION Free Inhibitor Target • Deficient
Plasma (0% Factor -X') Normal Plasma ( 100% Factor "X") 1:1 Mix (50% Factor "X
") ...
Robert I. Handin, Samuel E. Lux, Thomas P. Stossel,
2003
4
Advanced Nutrition and Human Metabolism
Fibrin Sequence of reactions ➀ Inactive clotting factor X ➁ Vitamin K and Calcium
➃ Fibrinogen Prothrombin (factor II) Factor Xa ➂ Thrombin (factor IIa) Fibrin (
soluble) ➃ Fibrin stabilizing factor (XIIIa) Fibrin (insoluble) A series of reactions ...
Sareen Gropper, Jack Smith,
2008
5
Handbook of Pediatric Transfusion Medicine
Types of Clotting Factor for Treating Hemophilia Clotting factor concentrates
come from two sources, either human plasma donations or production via
recombinant methods from cell cultures. Currently produced human plasma-
derived factor ...
Christopher D. Hillyer, Christopher Hillyer, Ronald Strauss,
2004
6
Biological Monitoring: An Introduction
There is no Factor VI because it has been shown to be activated Clotting Factor V
(Clotting Factor Va: accelerator globulin or proaccelerin). Coagulation involves
interaction of plasma proteins to form a stable fibrin gel. ultimately leading to clot
...
7
Thrombosis and Hemorrhage
The severity of bleeding correlates with the plasma concentration of the clotting
factor (37). Those with a level of factor VIII less than 1% of normal (i.e., severe
hemophilia) have spontaneous hemorrhages and ecchymoses, usually develop
...
Joseph Loscalzo, Andrew I. Schafer,
2003
8
The Absite Question Review Book: Basic Sciences Edition
Exposed collagen, prekallikrein, HMW kininogen, and Clotting Factor 12. What is
the extrinsic pathway activated by? Tissue factor and Clotting Factor 7. Which
clotting factor is the convergence point of both extrinsic and intrinsic pathways?
William M. Greenberg,
2010
9
Medical-surgical Nursing: Patient-centered Collaborative Care
Coagulation or bleeding disorders can result from a clotting factor defect. Defects
include the inability to produce a specific clotting factor, production of low
quantities of a clotting factor, or production Of a less active form of a clotting factor
.
Donna D. Ignatavicius, M. Linda Workman,
2012
10
Consultative Hemostasis and Thrombosis: Expert Consult - ...
Factor VIII dose to be administered = % factor IX dose; 1 U factor VIII concentrate
per kilogram is estimated to raise the clotting factor VIII activity level in plasma by
2%. Consider the use of recombinant factor VIII or IX concentrates in those ...
ȘTIRI NOI CARE INCLUD TERMENUL «CLOTTING FACTOR»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
clotting factor în contextul următoarelor știri.
Omega 3: What is benefits and its source
Omega-3 (EPA) good for the heart: lowers blood pressure, prevents hardening of the arteries and reduces the clotting factor in the blood that ... «Standard Republic, Iul 15»
Hemophilia Therapeutics Market – Global Industry Analysis and …
Hemophilia is a rare, inherited disorder in which blood doesn't clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a ... «Medgadget.com, Iun 15»
Biotech Stocks for you to follow - Biogen Inc (NASDAQ:BIIB …
ALPROLIX is a recombinant, clotting factor IX therapy and is currently approved for the treatment of hemophilia B in the U.S., Canada, Japan ... «Wall Street Observer, Iun 15»
EMA accepts marketing authorization application of Alprolix for …
Alprolix is a recombinant, clotting factor IX therapy and is currently approved for the treatment of haemophilia B in the US, Canada, Japan and ... «pharmabiz.com, Iun 15»
Sisters tells how their worst fears came true when they passed on …
Both sisters need clotting factor replacement if they have an operation because of their risk of bleeding. They didn't know anything about ... «Scottish Daily Record, Iun 15»
Large Cap Stocks Buzz - Baxter (BAX), Kinder Morgan (KMI …
Individuals with hemophilia B lack the ability to produce clotting factor IX and are today treated with infusions of plasma-derived or recombinant ... «Techsonian, Iun 15»
Biogen and Sobi Announce European Medicines Agency Validates …
ALPROLIX is a recombinant, clotting factor IX therapy and is currently ... therapy to demonstrate prolonged clotting factor circulation in the body. «MarketWatch, Iun 15»
Novo Nordisk reports positive results from phase 3 trial of Novoeight …
... people with hemophilia A must replace the missing factor VIII protein, which is accomplished by intravenous injection of the clotting factor. «pharmabiz.com, Iun 15»
Hot Action in 3 Biotech Stocks -Kite Pharma Inc (NASDAQ:KITE …
The company, on June 09, 2015, declared that the company will present new data on its long-acting clotting Factor VIIa-CTP (MOD-5014) at the ... «Wall Street Observer, Iun 15»
Novoeight provided long-term efficacy and safety in the treatment of …
... muscles, or organs because they are missing this clotting factor. To manage the disease and stop bleeding, people with haemophilia A must ... «European Pharmaceutical Review, Iun 15»